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012.07.0Abstract Background: Femoral artery pseudoaneurysm (FAP) is a troublesome complication
after transfemoral catheter procedures. The incidence and predictors of FAP as a separate entity
have not been extensively studied.
Aim: Detect prospectively the incidence and predictors of post catheterization FAP.
Methods: From June 2009 till June 2011, we prospectively included all patients who underwent
catheterization from the femoral approach. Duplex ultrasound was performed in cases with clinical
suspicion of vascular complications. Clinical data and procedural variables were compared with a
control group of 200 randomly selected patients. We performed univariate analysis and a logistic
regression model for multivariate analysis.
Results: The incidence of FAP was 3.42%. Eighty FAPs (66.7%) were related to a diagnostic cath-
eterization while 40(33.3%) were related to an interventional procedure. The mean age of patients
with FAP was 55.36 ± 10.68 yrs; 57.5% were females. At diagnosis 81.66% of the patients were on
antiplatelet therapy, 35% were on heparin or warfarin and 16.66% were on both, with mean value
of INR for patients on warfarin 2.2 ± 0.76. FAPs were connected to the common femoral artery in
29.1% of patients, to the SFA in 54.1% and to the profunda in 16.6%. Female gender, obesity and
hypertension signiﬁcantly enhanced the risk for FAP. Also diagnostic angiography, low puncture,
multiple punctures and the use of dual antiplatelet and/or anticoagulant therapy were independent
procedure-related risk factors for FAP.udoaneurysm; CFA, common
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Figure 1 Post-catheterization femor
214 H.H. Kassem et al.Conclusion: Femoral artery pseudoaneurysms are not uncommon. Female gender, obesity, hyper-
tension, the use of antiplatelet and/or anticoagulant therapy and faulty puncture techniques are
independent risk factors for FAPs.
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Femoral artery pseudoaneurysm (FAP) is one of the trouble-
some groin complications related to the femoral arterial access
site used for invasive cardiovascular procedures. The pseudo-
aneurysm is a contained rupture where there is a disruption
in all three layers of the arterial wall. Under the inﬂuence of
sustained arterial pressure, blood dissects into the tissues
around the damaged artery and forms a perfused sac that com-
municates with the arterial lumen. The perfused sac (Fig. 1) is
contained by the media or adventitia or simply by soft tissue
structures surrounding the injured vessel.1
The incidence of FAP after diagnostic catheterization
ranges from 0.05% to 2%. When coronary or peripheral inter-
vention is performed, the incidence increases from 2% to 6%.3
FAPs are commonly encountered when more complex coro-
nary or peripheral interventions are performed, especially with
the use of larger-sized introducer sheath, potent antithrom-
botic and antiplatelet therapy.4
Pseudoaneurysms may be asymptomatic and detected only
incidentally during radiologic investigation of other condi-
tions. The presence of pain or swelling in the groin after cath-
eterization is the most common presentation of a FAP.
Clinical examination may reveal thrill or bruit, pulsatile hema-
toma, or marked tenderness at the site of arterial puncture.
Complications of FAPs may result from compression of nerves
and vessels with associated neuropathy, venous thrombosis,
claudication, or, rarely, critical limb ischemia. Local ischemiaal artery pseudoaneurysm.2of the skin may lead to necrosis and infection, whereas the
most catastrophic event is rupture.5 Duplex scanning is the
best modality for diagnosis of pseudoaneurysms especially in
the femoral arteries. Duplex ultrasound distinguishes FAP
from hematoma or arterio-venous ﬁstulae, gives precise ana-
tomical information, and measures velocities within the sac
and the neck.6 Conventional angiography remains the gold
standard for diagnosis.
According to the ACC/AHA guidelines for the management
of patients with peripheral arterial disease; small asymptomatic
pseudoaneurysms probably can be managed conservatively un-
less they are still present on a follow-up duplex scan 2 months
later. At the opposite extreme, large or symptomatic FAPs
can rupture into the retroperitoneal space or the upper thigh
or cause venous thrombosis or painful neuropathy by com-
pressing the adjacent femoral vein or the femoral nerve and
should be subjected to one of the different available treating
modalities.7 Various approaches for the management of pseud-
oaneurysms have been introduced; with ultrasound guided
compression repair and surgical revision being the most estab-
lished methods.
Most of the published series examined the incidence of
post-catheterization vascular complications collectively (bleed-
ing, hematoma, dissection, thrombosis, AV ﬁstula and pseudo-
aneurysm) with no speciﬁc analysis for pseudoaneurysms.8,9
Also, there are only a few prospective published studies that
describe the predictors of FAP after cardiac catheterization.
To our knowledge, no prospective studies were conducted in
Egypt to explore the incidence and predictors of post-catheter-
ization femoral pseudo-aneurysms.2. Patients and methods
We prospectively enrolled all patients who underwent coro-
nary angiography (CA), left heart catheterization and/or per-
cutaneous cardiac intervention (PCI) in the cardiovascular
department, Cairo University hospital from June 2009 till June
2011. All patients were examined by the medical staff before
and after CA/PCI including auscultation of the groin. The
use of single or dual antiplatelet, heparin and IIB/IIIA blocker
was left to the discretion of the performing physician. The
groin sheath was removed immediately in the case of a diag-
nostic procedure. Groin sheath removal was delayed until
4 h of the interventional procedure after discontinuation of
heparin and until the activated partial thromboplastin time
was in a safe range (<35 s). Manual compression was used
in all patients for 10–15 min or until the puncture site has been
secured of bleeding, and then compression bandage was kept
for another 6 h.
Duplex scanning was performed in patients who were sus-
pected of having local groin vascular complications based on
the presence of one or more of the following ﬁndings at the
puncture site:
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 Extensive skin discoloration or ecchymosis
 Palpable or pulsatile mass
 Thrill or bruit
Duplex scanning was performed using Sonoline Elegra V6.0
(Siemens Corporation, Munich, Germany), ATL HDI 5000
and HP Sonos 2000 (Philips, Eindhoven, Netherlands) sys-
tems. All had high resolution broadband width linear array
transducers L5-7/10 MHz. In patients who had extensive
inguinal hematomas, a 3.5-MHz transducer was used addition-
ally to better visualize the FAP geometric features and to
ascertain the FAP position in relation to the artery. Duplex
scanning criteria used to diagnose a pseudoaneurysm were:
swirling color ﬂow seen in a mass separate from the affected
artery, color ﬂow within a tract leading from the artery to
the mass consistent with pseudoaneurysm neck, and the mostFigure 2 Duplex scan features of pseudoaneurysms. Left panel: colo
cavity. Right panel: characteristic Doppler waveform at the neck (to &
Figure 3 Triphasic Doppler waveform in the pimportant was the typical ‘‘to and fro’’ Doppler waveform
(Fig. 2) in the pseudoaneurysm neck.10
The following parameters were reported during the scan-
ning in cases with fulﬁlled duplex criteria of FAP:
1. The status of arterial wall at the common femoral artery
(CFA) either healthy or atherosclerotic.
2. The Doppler waveform in the ipsilateral popliteal and
infra-popliteal arteries (triphasic, monophasic damped, or
absent) Fig. 3.
3. Presence or absence of spontaneous thrombosis within the
FAP cavity or lining its wall (Fig. 4).
4. Number of lobes of FAP, either one lobe (uniloculated) or
more than one lobe (multiloculated).
5. Feeding artery; common femoral, superﬁcial femoral (SFA)
or profunda femoris (PFA). The feeding artery was consid-
ered as the same artery punctured during catheterization.r Doppler image, showing swirling color ﬂow in pseudoaneurysm
fro).
osterior tibial artery in a patient with FAP.
Figure 4 B-mode ultrasound showing a FAP with no thrombosis in the cavity.
216 H.H. Kassem et al.6. Dimensions of the FAP; namely length, width, height and
volume. The length, width and height are three diameters
of FAP two of them are perpendicular to each other and
the third is oblique by approximately 60 to one of them.11
The volume was calculated by the formula:
Volume ¼ length widthHeight 0:5
12,13
For patients with a diagnosed FAP using duplex scanning,
we collected the following data:
 Baseline clinical data: age, gender, traditional risk factors of
atherosclerosis as diabetes, hypertension (HTN), obesity,
smoking, and positive family history of CAD.Figure 5 Duplex scan of a thrombosed FA History of previous catheterization.
 Physical signs at the puncture site: pain, skin discoloration,
mass, bruit or thrill.
 Onset of presentation after the procedure: within 3 days, 3–
7 days or >7 days.
 Body mass index (BMI) calculated according the formula:
BMI (kg/m2) = weight/height2. Overweight was deﬁned as
BMI from 25–29.9 kg/m2, obesity was deﬁned as BMI from
30–39.9 kg/m2 and morbid obesity was diagnosed as
BMIP 40 kg/m2.14
 Examination of the pedal pulsations.
 Systolic blood pressure (SBP) and diastolic blood pressure
(DBP) at the time of catheterization.
 Type of the procedure; diagnostic or intervention.P after ultrasound guided compression.
Table 1 Demographic features and risk factors of atheroscle-
rosis among patients with FAP.
Variable N (%)
Age (years) 55.36 ± 10.68
Females 69 (57.5%)
Hypertension 72 (60%)
Diabetes 54 (45%)
Smoking 30 (25%)
Family history of coronary artery disease 33 (27.5%)
Table 2 Groin examination and time of presentation of
patients with FAPs.
Variable N (%)
Groin mass 115 (98.3%)
Skin discoloration 45 (37.5%)
Pain 25 (20.8%)
Audible bruit 118 (95.8%)
Presented within 3 days 69 (57.5%)
Presented within 3–7 days 45 (37.5%)
Presented within after 7 days 6 (5%)
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 Gauge of introducer sheath.
 Time of mobilization after the procedure in hours.
 The use of single (aspirin or clopidogrel) or dual antiplatelet
(aspirin + clopidogrel).
 The use of ﬁbrinolytic therapy before the procedure.
 The use of low molecular weight heparin (LMWH) before
the procedure.
 The use of warfarin before the procedure.
 The international normalized ratio (INR) value for patients
on warfarin.
Patients who had deﬁnitive diagnosis of post catheteriza-
tion FAP were subjected immediately after the duplex scan-
ning to one of the available management modalities (e.g.,
ultrasound guided compression repair, para-aneurysmal saline
injection, thrombin injection or surgical repair) Fig. 5.
To establish a control group, we randomly selected 200 pa-
tients without FAP (by picking the 15th patient in sequence).
In the control group, we performed a Duplex scan to exclude
the presence of FAPs and collected the same data collected in
patients with a documented FAP. However, in patients with-
out FAPs, it was not possible to locate the puncture site by du-
plex scanning.
3. Statistical analysis
Statistical analysis was performed using the statistical package
for social sciences (SPSS), IBM corporation, New York, USA.
The incidence of FAP is given as percentage of all included pa-
tients. The data of metric variables (age, weight, height, and
BMI) are given as mean and standard deviation. For the uni-
variate analysis, the mean values and proportions of baseline
variables were compared between the FAP and control groups
by using Pearson’s v2 test or one-way analysis of variance
(ANOVA). Reference to statistical signiﬁcance was made by
presenting a p value for a risk of 5%; thus, any measurement
with a value of P< 0.05 was considered statistically
signiﬁcant.
To determine independent risk factors for FAP, the Fisher
exact test for univariate analysis was performed. Also, a logis-
tic regression model for multivariate analysis was performed.
For this purpose, metric variables (age, BMI) and non-metric
variables (sheath size and procedural heparin dosage) were
transferred into dichotomized variables. We chose that method
to study the inﬂuence of some variables like low puncture site
and feeding artery as these variables could not exist in patients
with no FAPs. The odds ratio (OR) with 95% conﬁdence inter-
val (CI) was calculated to determine the relative risk of each
suspected risk factor. Statistical signiﬁcance was considered
when 95% CI of the multivariate OR exceeded the value of
one.
4. Results
In this study we recruited prospectively 3500 patients who
underwent cardiac catheterization in our catheterization labo-
ratory, from June 2009 till June 2011. All the recruited patients
had undergone catheterization via femoral access. Two thou-
sand patients underwent diagnostic procedures, and 1500
underwent interventional procedures. We diagnosed 120patients with post-catheterization FAP out of 3500 patients
(3.43%). Eighty FAPs (66.7%) were related to a diagnostic
catheterization while 40 (33.3%) were related to an interven-
tional procedure. The incidence of FAP after a diagnostic
catheterization was 4% and was 2.67% after an interventional
catheterization.
The mean age of patients with FAP was 55.36 ± 10.68
years, 69 patients (57.5%) were females. Thirty patients
(25%) were smokers, 72 (60%) were hypertensive, 54 (45%)
were diabetics, 54 (45%) had dyslipidemia and 33 (27.5%)
had a positive family history of ischemic heart disease Table 1.
The SBP was 145.38 ± 29.99 mmHg, while the DBP was
86 ± 14.59 mmHg. The local physical signs at the groin and
the time of presentation after cardiac catheterization are illus-
trated in Table 2. A mass was detected at the puncture site in
115 (98.3%) patients, while thrill and bruit were detected in
118 (95.8%) patients. Pedal pulsations were intact in all pa-
tients at the time of presentation.
The incidence of features that may predispose for post-
catheterization FAP is illustrated in Table 3.
The mean value of INR for patients on oral anticoagulant
therapy was 2.2 ± 0.76.
Data obtained from duplex scanning showed that the arte-
rial wall of the CFA was healthy in 78 patients (65%), while
diffuse atherosclerosis was detected in 42 (35%) of patients.
FAPs were connected to the CFA in 35 patients (29.1%), 65
(54.1%) were connected to the SFA while 20 (16.6%) were
connected to profunda femoris. Pseudoaneurysms cavities
were partially thrombosed in 60 (50%) patients. Doppler
waveform in the pedal arteries was triphasic in all examined
patients. Other features detected by duplex scanning are illus-
trated in Table 4.
Female gender, hypertension and obesity were more fre-
quent in patients with FAP compared to controls. Diagnostic
studies, multiple arterial punctures and the use of dual anti-
Table 3 Incidence of variables possibly predisposing to FAP.
Variable (n= 120)%
Patient-related variables
Overweight 33 (27.5%)
Obesity 55 (45.8%)
Morbid obesity 15 (12.5%)
Previous coronary angiography 20 (16.7%)
Fibrinolytic therapy 18 (15%)
Aspirin 30 (25%)
Aspirin and clopidogrel 48 (40%)
Aspirin, clopidogrel & LMWH 10 (8.3%)
Warfarin 22 (18.3%)
Aspirin & warfarin 10 (8.3%)
Procedure-related variables
Diagnostic angiography 80 (66.6%)
Coronary intervention 40 (33.3%)
6F sheath 110 (91.7%)
7F sheath 10 (8.3%)
Multiple punctures 65 (54.1%)
Mobilized within 6 h 30 (25%)
Mobilized within 6–24 h 56 (46.7%)
Mobilized after 24 h 34 (28.3%)
218 H.H. Kassem et al.platelet or antithrombotic therapy were also more common in
the FAP group Table 5.
By univariate analysis, hypertension, diagnostic procedure,
multiple punctures, puncture a vessel other than the CFA, the
use of anticoagulation, the use of dual antiplatelet therapy or
both were signiﬁcantly associated with increased risk for devel-
oping FAP. By multivariate analysis, the same variables wereTable 4 Data obtained from duplex scanning.
Variable (n= 120)
Uniloculated FAPs 85 (70.8%)
Multiloculated FAPs 35 (29.16%)
Single neck 80 (66.66%)
Multiple necks 40 (33.33%)
Mean width of the neck 1.87 ± 0.28 cm
Table 5 Comparison between risk factors in the FAP group and th
Risk factor FAP group (n=
Patient related factors
Age (years) 55.36 ± 10.68
Female gender 69 (57.5%)
Hypertension 72 (60%)
BMI (kg/m2) 33.2 ± 3.4
Diabetes 54 (45%)
Dyslipidemia 54 (45%)
Smoker 33 (27.5%)
Procedure related factors
Diagnostic CA 80 (66.6%)
Multiple punctures 65 (54.1%)
Sheath size (7F) 10 (8.3%)
Low puncture distal to the CFA 85 (70.8%)
Early mobilization after CA (within 6 h) 30 (25%)
Dual antiplatelet and/or anticoagulant 90 (75%)independently associated with FAP, in addition to female gen-
der. In contrast, the size of the introducer sheath, interven-
tional CA and early mobilization after CA, were of no
signiﬁcant relevance Table 6.
5. Discussion
In published series, the incidence of post catheterization vascu-
lar complication varied from 0.2% to 6%.15,16 Tavris et al.17
described an overall 3.4% rate of vascular complications fol-
lowing diagnostic cardiac catheterization. In another series18
the rate of vascular complications after interventional cathe-
ter-based procedures varied from 2% to 6%. A multicenter
registry of more than 18,000 patients undergoing PCI also re-
ported a 3% vascular complication rate.16 A meta-analysis of
more than 35,000 patients identiﬁed an overall vascular com-
plication rate of 3.3% for femoral artery access.19 The inci-
dence of local puncture-related complications will probably
increase in the future owing to the increasing number of radio-
logic and cardiovascular interventions being performed in gen-
eral, longer catheter dwelling times, larger sheath sizes, and the
incremental use of antiplatelet and anticoagulation therapy for
these procedures.
In our study we spotted 120 patients with femoral pseud-
oaneurysms which is the largest number recorded in the litera-
ture, to our knowledge, in two years. Most of the FAPs were
after diagnostic procedures. The incidence of FAP (3.42%)
in our study is comparable to the ranges reported in published
studies. However, the incidence of FAP following diagnostic
procedures was much higher (4%). We believe that the high
incidence of FAPs after diagnostic catheterization can beVariable (n= 120)
Mean length of the neck 4.05 ± 0.72 cm
Mean FAP length 4.79 ± 0.94 cm
Mean FAP width 4.26 ± 0.83 cm
Mean FAP height 4.39 ± 0.80 cm
Mean FAP volume 46.24 ± 22.73 cm3
e control group.
120) Control group (n= 200) P value
54.27 ± 12.34 NS
45 (22.5%) 0.04
50 (25%) 0.04
27.34 ± 1.22 0.045
100 (50%) NS
96 (48%) NS
60 (30%) NS
52 (26%) 0.02
33 (16.5%) 0.005
17 (8.5%) NS
N/A –
60 (30%) NS
57 (28.5%) 0.005
Table 6 Risk-adjusted multivariate logistic regression analysis concerning incidence of FAP.
Risk factors Dichotomization Univariate analysis Multivariate analysis
P value Odds ratio (95% CI) P value Odds ratio (95% CI)
Patient-related factors
Age 660 vs. P61 years 0.106 1.49 0.301 1.32
(0.91–2.43) (0.78–2.22)
Gender Male vs. female 0.14 1.53 0.03 1.84
(0.92–2.55) (1.06–3.20)
BMI Normal vs. obese 0.13 1.03 0.04 1.74
(0.61–1.72) (1.08–2.99)
HTN Normotensive vs. hypertensive 0.013 1.92 0.022 1.85
(1.15–3.22) (1.08–3.15)
Procedure-related factors
Type of the procedure Diagnostic vs. PCI 0.04 1.84 0.03 2.22
(1.23–3.11) (1.06–3.22)
No. of punctures Single vs. multiple 0.018 2.35 0.036 2.21
(1.19–4.33) (1.05–4.55)
Feeding artery CFA vs. others 0.006 2.11 0.023 2.89
(1.25–3.67) (1.06–5.34)
Sheath size 6F vs. 7F 0.23 1.32 0.33 1.43
(0.8–2.22) (0.76–2.04|)
Mobilization after CA Early vs. late 0.53 1.20 0.588 0.85
(0.73–1.98) (0.45–1.58
Anticoagulant ± 0.053 2.01 0.039 2.84
(1.62–3.55) (1.66–4.95)
Dual antiplatelet ± 0.052 1.99 0.046 2.22
(1.02–2.98) (1.32–4.78)
Dual antiplatelet and/or anticoagulant ± 0.056 2.12 0.035 2.34
(1.01–4.44) (1.06–5.18)
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perform femoral puncture guided by palpation and by superﬁ-
cial landmarks as the anterior superior iliac spine and the
inguinal crease. Only a few operators perform the puncture
with ﬂuoroscopic guidance to locate the level of the head of
the femur. The result could be puncturing the SFA in obese
individuals with a ‘‘redundant’’ inguinal skin crease. The sec-
ond reason is the common practice of removing the sheath
in the cathlab immediately after the procedure. Most patients
are given heparin at the start of the procedure but only a
minority of operators orders an activated clotting time
(ACT) test before removing the groin sheath after the diagnos-
tic angiography. It may be necessary in some patients to re-
verse the effects of heparin with protamine. Another
explanation is that groin sheaths after diagnostic procedure
are usually removed by cathlab nurses whereas after PCI, the
sheath is removed in the resident in the ICU, usually with
greater care.
We found that female gender, obesity, hypertension, and
the use of dual antiplatelet and/or anticoagulant therapy prior
to catheterization were independent risk factors for developing
FAPs. An inappropriate low puncture site and multiple punc-
tures attempts were also risk factors for FAPs. On the other
hand, age, other traditional risk factors of atherosclerosis, size
of introducer sheath, an interventional procedure, previous
history of catheterization from the same site, and early mobi-
lization after CA were of no signiﬁcant relevance.
The reported risk factors for FAP in the literature20 include
procedural factors: interventional rather than diagnostic pro-
cedures, catheterization of both artery and vein, low femoralpuncture causing catheterization of the SFA or profunda,
and inadequate compression post-procedure. The reported pa-
tient-related factors include obesity, the use of anticoagulation,
hemodialysis and calciﬁed femoral arteries. Other investiga-
tors21 found that no patient-related factors contributed signif-
icantly to FAP, only procedure-related factors as sheath size
and interventional nature appeared as FAP risk factors. Ates
et al. found that factors independently predictive of FAP were
hypertension (P= 0.011; OR 1.52), diabetes mellitus (P=
0.035; OR 1.11), coronary artery disease (P= 0.022; OR
1.21), BMIP 28 kg/m2 (P< 0.001; OR, 2.21), larger num-
ber of cases performed per day in a particular room (P<
0.001; OR 2.39), and larger (>7F) catheter diameter (P<
0.001; OR 2.82).22
Female gender arose in our study to be an independent risk
factor for FAP. This could be explained by the higher inci-
dence of bleeding in general and local hematomas with PCI
in females.23,24 Hypertension also came as an independent risk
factor probably due to the difﬁculty in compressing an artery
with an elevated intra-luminal pressure. Some studies showed
hypertension to have no effect on the development of FAPs21
while others found HTN to be independently associated with
FAPs.22
We found FAPs in 32 patients who were on Warfarin be-
fore catheterization; mean INR 2.2 ± 0.76. It is our standard
practice to stop Warfarin before catheterization till the INR
gets <1.8. However, in some cases it was not possible to stick
to the standard protocol. This could happen when cardiac
catheterization is performed before emergency valve surgery
or in patients on warfarin who develop acute coronary syn-
220 H.H. Kassem et al.dromes and require urgent catheterization. In fact, transfemor-
al angiography in patients on warfarin with an INR of 2.0–3.0
was described in some series to be safe25 with an incidence of
access site complications not higher than that in patients with
a warfarin pause or in patients with pause and bridging
therapy.26
In fact, the strongest risk factor for FAP formation (OR
2.89) was puncture below the CFA. The best manual com-
pression forces are achieved for the compression of arterial
segments located at the femoral head, i.e., for CFA. Compres-
sion exerted below this structure lacks sufﬁcient support
which limits its efﬁcacy. This has been demonstrated by
Gabriel et al. who found that the risk of aneurysm formation
was 8.7% with puncture of the SFA or profunda compared to
3.1% with CFA puncture.27 Faulty puncture is a major
predictor of post catheterization FAP formation and also is
the most preventable risk factor. Vascular complications are
much less common when the interventionist uses ultrasound28
or ﬂuoroscopy with localization of the femoral head29 to
puncture the femoral artery in the correct location and with
the ﬁrst attempt, especially in obese patients and those with
weak pulses.30
6. Conclusion
Femoral artery pseudoaneurysm is not an uncommon vascular
complication following diagnostic or interventional cardiac
catheterization and probably will increase. The strongest
predictors of FAP are punctures below the CFA, multiple
punctures, female gender, hypertension, and the use of anti-
platelet and/or antithrombotic therapy. The use of 7F sheath,
early mobilization and previous catheterization were not pre-
dictors of pseudoaneurysm formation. Attention to puncture
under ﬂuoroscopic guidance is strongly recommended.
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